Beyond the Sandbag: How the GRAIL Readout Could Reignite Twist Bioscience in '26Inflecting quality + inflecting income statement = violence in the share priceBack of the Napkin BiosNov 28, 2025∙ Paid125ShareThis post is for paid subscribersSubscribeAlready a paid subscriber? Sign in
